Effect of dexmedetomidine on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
- VernacularTitle:右美托咪定用于预防腹腔镜胆囊切除术后恶心呕吐的效果
- Author:
Minghui CHEN
;
Hongli YU
;
Tao CHANG
;
Shukun FU
;
Hui LI
;
Fuqing LIN
- Keywords:
Dexmedetomidine;
Laparoscopic cholecystectomy;
Postoperative nausea and vomiting
- From:
The Journal of Clinical Anesthesiology
2017;33(3):261-263
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effectiveness of dexmedetomidine on postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy.Methods Seventy patients (17 males,53 females,aged 20-65 years,ASA grade Ⅰ or Ⅱ) undergoing laparoscopic cholecystectomy were randomized to receive either dexmedetomidine (group R,n=35) or dexamethasone (group D,n=35).The patients in the group R received 0.5 μg/kg bolus dose and maintenance dose at the rate of 0.5 μg·kg-1·h-1 of dexmedetomidine before intubation.The patients in the group D received 8 mg dexamethasone before intubation.The BP and HR were recorded at the following points: on arrival in the operating room (T1),before intubation (T2),5 minutes after intubation (T3),5 minutes after the beginning of the operation (T4),30 minutes after the beginning of the operation (T5),at the end of operation (T6) and 5 minutes after extubation (T7).The inhaling concentration of sevoflurane,extubation time,operation time and anesthesia time were recorded.The incidence of nausea and vomiting were recorded at 8,24,48 hours after operation.Results The incidence of nausea and vomiting at each point were similar between two groups.The HR at T2-T7 in group D was significantly lower.But MAP was similar between two groups.Conclusion 0.5 μg/kg bolus dose and maintenance dose at the rate of 0.5 μg·kg-1·h-1 of dexmedetomidine reduced the incidence of PONV in patients undergoing laparoscopic cholecystectomy,similar to dexamethasone.
